26 August 2021 in Journal of General Virology
Viperin is a gene with a broad spectrum of antiviral functions and various mechanisms of action. The role of viperin in herpes simplex virus type 1 (HSV-1) infection is unclear, with conflicting data in the literature that is derived from a single human cell type. We have addressed this gap by investigating viperin during HSV-1 infection in several cell types, spanning species and including immortalized, non-immortalized and primary cells. We demonstrate that viperin upregulation by HSV-1 infection is cell-type-specific, with mouse cells typically showing greater increases compared with those of human origin. Further, overexpression and knockout of mouse, but not human viperin significantly impedes and increases HSV-1 replication, respectively. In primary mouse fibroblasts, viperin upregulation by infection requires viral gene transcription and occurs in a predominantly IFN-independent manner. Further we identify the N-terminal domain of viperin as being required for the anti-HSV-1 activity. Interestingly, this is the region of viperin that differs most between mouse and human, which may explain the apparent species-specific activity against HSV-1. Finally, we show that HSV-1 virion host shutoff (vhs) protein is a key viral factor that antagonises viperin in mouse cells. We conclude that viperin can be upregulated by HSV-1 in mouse and human cells, and that mouse viperin has anti-HSV-1 activity.
19 December 2025 in Science Advances
CD8 + T cells are essential effectors in antiviral immunity that kill infected cells displaying viral peptide epitopes on major histocompatibility complex class I (MHC I). The pathways underpinning antigen presentation on MHC I are well known, but we lack a quantitative understanding of the relationships between source proteins and presented epitopes and how these relate to immunogenicity. We used mass spectrometry to interrogate vaccinia virus infection to reveal that up to 90% of epitopes were presented as fast as their source proteins were translated, but that protein amounts failed to correlate with epitope levels. Unexpectedly, epitope levels on infected cells also failed to correlate with immunogenicity. However, by extending our analysis to produce the first measurements of viral epitope levels from infected mice, we found a significant but moderate correlation with immunogenicity. These data provide empirical evidence for and against several associations that to date have been assumed or are not well resolved.